Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial
3 minutes
Posted Sep 12, 2025 at 6:51 pm.
0:00
3:37
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
NACA is a gene-agnostic, oral medication designed to preserve vision in people with retinitis pigmentosa and Usher syndrome.
Previous
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
Next
Agnes Gund – Renowned Philanthropist, Social Justice Champion, and Art Patron – Passes Away
← See all 261 episodes of Foundation Fighting Blindness